Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Filter
  • 1-10 of  11,673 results for ""hodgkin lymphoma""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Global burden, risk factors, and trends of non-Hodgkin lymphoma: A worldwide analysis of cancer registries.

  • Authors : Huang J; The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong SAR, China.; Centre for Health Education and Health Promotion, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.

Subjects: Lymphoma, Non-Hodgkin*/Lymphoma, Non-Hodgkin*/Lymphoma, Non-Hodgkin*/epidemiology ; Lymphoma*/Lymphoma*/Lymphoma*/epidemiology; Humans

  • Source: Cancer medicine [Cancer Med] 2024 Mar; Vol. 13 (5), pp. e7056.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Difficulty differentiating primary mediastinal classical Hodgkin lymphoma from inflammatory myofibroblastic tumor: A case report.

  • Authors : Akata K; Division of Infection Control and Prevention, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.; Department of Respiratory Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.

Subjects: Hodgkin Disease*/Hodgkin Disease*/Hodgkin Disease*/diagnosis ; Hodgkin Disease*/Hodgkin Disease*/Hodgkin Disease*/drug therapy ; Hodgkin Disease*/Hodgkin Disease*/Hodgkin Disease*/pathology

  • Source: Thoracic cancer [Thorac Cancer] 2024 Feb; Vol. 15 (5), pp. 410-414. Date of Electronic Publication: 2023 Dec 30.Publisher: Wiley Publishing Asia Pty Ltd Country of Publication: Singapore NLM ID: 101531441 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Report

A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma

  • Source: A Phase 1/2a, Open-Label, Dose Escalation Trial of GEN3017 With Expansion Cohorts in Relapsed or Refractory CD30+ Classical Hodgkin

Record details

×
Report

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

  • Source: A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy With Immuno-oncology Therapy for Children and Adults With Newly Diagnosed Stage I and II Classic

Record details

×
Report

Sintilimab Plus AVD in Pediatric Low/Moderate Risk Hodgkin Lymphoma: a Phase II Study

  • Authors : Yizhuo Zhang, Prof

  • Source: Prospective, Single-Arm, Multicenter, Phase II Study of Sintilimab in Combination with AVD for Pediatric and Adolescent Low/Moderate Risk Classical Hodgkin

Record details

×
Report

Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma

  • Source: NORM: Nodular Lymphocyte-Predominant Hodgkin Lymphoma Patients Treated in a Randomized Phase 2 Trial With Either Rituximab or

Record details

×
Report

Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma

  • Source: A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and

Record details

×
Report

Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma

  • Source: A Randomized Phase II Trial of Ofatumumab and Bendamustine vs. Ofatumumab, Bortezomib (NSC # 681239) and Bendamustine in Patients With Untreated Follicular Lymphoma

Record details

×
  • 1-10 of  11,673 results for ""hodgkin lymphoma""